Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hypoxia D000860 23 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
pmid:
Tselepis AD et al. Association of the inflammatory state in active juvenile rheumatoid arthritis with hypo-high-density lipoproteinemia and reduced lipoprotein-associated platelet-activating factor acetylhydrolase activity. 1999 Arthritis Rheum. pmid:10025933
Bussolati B et al. Interleukin-12 is synthesized by mesangial cells and stimulates platelet-activating factor synthesis, cytoskeletal reorganization, and cell shape change. 1999 Am. J. Pathol. pmid:10027419
Van de Weerdt ML et al. Ketoprofen and phenylbutazone attenuation of PAF-induced lung inflammation in calves. 1999 Vet. J. pmid:10030127
Zallen G et al. Postinjury suppression of human neutrophil cytokine production results from the stabilization of inhibitory kappaB. 1999 Shock pmid:10030791
Delong P et al. Bacterial lipopolysaccharide induction of the prostaglandin G/H synthase 2 gene causes thromboxane-dependent pulmonary hypertension in rabbits. 1999 Am. J. Respir. Cell Mol. Biol. pmid:10030848
Mukherjee PK et al. Glutamate receptor signaling interplay modulates stress-sensitive mitogen-activated protein kinases and neuronal cell death. 1999 J. Biol. Chem. pmid:10037742
Tsuchiya R et al. Role of platelet activating factor in development of thrombocytopenia and neutropenia in dogs with endotoxemia. 1999 Am. J. Vet. Res. pmid:10048555
Okayama N et al. Intracellular mechanisms of hydrogen peroxide-mediated neutrophil adherence to cultured human endothelial cells. 1999 Microvasc. Res. pmid:10049654
Satoh N et al. Plasma platelet-activating factor acetylhydrolase deficiency in Japanese patients with asthma. 1999 Am. J. Respir. Crit. Care Med. pmid:10051281
Tokumura A et al. Substrate specificity of lysophospholipase D which produces bioactive lysophosphatidic acids in rat plasma. 1999 Biochim. Biophys. Acta pmid:10064906
Stojanov T et al. In-vitro fertilization and culture of mouse embryos in vitro significantly retards the onset of insulin-like growth factor-II expression from the zygotic genome. 1999 Mol. Hum. Reprod. pmid:10065866
Kaminskaia GO et al. [Platelet activating factor in biological fluids of animals with different species-specific resistance at the stage of infective process after inoculation with mycobacterium tuberculosis]. 1998 Probl Tuberk pmid:10067355
Hurst J et al. PAF binding to a single receptor in corneal epithelium plasma membrane. 1999 Invest. Ophthalmol. Vis. Sci. pmid:10067986
Oguchi A et al. Platelet activating factor causes a rapid increase in activity of prior expressed tissue factor on monocyte surface membrane. 1999 Int. J. Hematol. pmid:10071462
Suzuki T et al. 2-(3-Pyridyl)thiazolidine-4-carboxamide derivatives. III.) Synthesis of metabolites and metabolism of 2-(3-pyridyl)thiazolidine-4-carboxamides YM461 and YM264 as platelet-activating factor (PAF) receptor antagonists. 1999 Chem. Pharm. Bull. pmid:10071851
Bartemes KR et al. Endogenous platelet-activating factor is critically involved in effector functions of eosinophils stimulated with IL-5 or IgG. 1999 J. Immunol. pmid:10072549
Zeng S and Guo ZG Mepyramine inhibits platelet activating factor-induced rabbit platelet aggregation: role of intracellular histamine. 1997 Zhongguo Yao Li Xue Bao pmid:10072970
Shohet RV et al. Plasma platelet-activating factor acetylhydrolase activity is not associated with premature coronary atherosclerosis. 1999 Am. J. Cardiol. pmid:10073795
Fink MP Nitric oxide and the gut: one more piece in the puzzle. 1999 Crit. Care Med. pmid:10075038
Qu XW et al. Roles of nitric oxide synthases in platelet-activating factor-induced intestinal necrosis in rats. 1999 Crit. Care Med. pmid:10075061
Bazan NG Bioactive lipids and gene expression in neuronal plasticity. 1998 Adv. Exp. Med. Biol. pmid:10079836
Takami M and Tsukada W Effect of DP-1904, a thromboxane synthetase inhibitor, on antigen- and spasmogen-induced bronchoconstriction in rodents. 1999 Eur. J. Pharmacol. pmid:10082207
Kim KA et al. Pinusolide from the leaves of Biota orientalis as potent platelet activating factor antagonist. 1999 Planta Med. pmid:10083843
Karasawa K et al. Purification and characterization from rat kidney membranes of a novel platelet-activating factor (PAF)-dependent transacetylase that catalyzes the hydrolysis of PAF, formation of PAF analogs, and C2-ceramide. 1999 J. Biol. Chem. pmid:10085103
Samples BL et al. Subcellular localization of enzyme activities involved in the metabolism of platelet-activating factor in rainbow trout leukocytes. 1999 Biochim. Biophys. Acta pmid:10101269
Kobayashi K et al. Platelet-activating factor receptor is not required for long-term potentiation in the hippocampal CA1 region. 1999 Eur. J. Neurosci. pmid:10103126
Uhl E et al. Influence of platelet-activating factor on cerebral microcirculation in rats: part 1. Systemic application. 1999 Stroke pmid:10187894
Uhl E et al. Influence of platelet-activating factor on cerebral microcirculation in rats: part 2. Local application. 1999 Stroke pmid:10187895
Oh-hashi K et al. Dietary alpha-linolenate suppresses endotoxin-induced platelet-activating factor production in rat kidney. 1999 Lipids pmid:10188594
Lim H et al. Inhibitory effect of sulfur-containing compounds in Scorodocarpus borneensis Becc. on the aggregation of rabbit platelets. 1999 Biosci. Biotechnol. Biochem. pmid:10192909
Park TS et al. Platelet-activating factor mediates ischemia-induced leukocyte-endothelial adherence in newborn pig brain. 1999 J. Cereb. Blood Flow Metab. pmid:10197511
Yamaguchi S et al. Effects of Y-24180, a receptor antagonist to platelet-activating factor, on allergic cutaneous eosinophilia in mice. 1999 Life Sci. pmid:10201647
Wang X et al. Inhibition of platelet-activating factor, intercellular adhesion molecule 1 and platelet endothelial cell adhesion molecule 1 reduces experimental pancreatitis-associated gut endothelial barrier dysfunction. 1999 Br J Surg pmid:10201790
Calcerrada MC et al. Glutamate release is involved in PAF-increased cyclic GMP levels in hippocampus. 1999 Biochem. Mol. Biol. Int. pmid:10204090
Held HD et al. Characterization of airway and vascular responses in murine lungs. 1999 Br. J. Pharmacol. pmid:10205008
Brizzi MF et al. Thrombopoietin stimulates endothelial cell motility and neoangiogenesis by a platelet-activating factor-dependent mechanism. 1999 Circ. Res. pmid:10205146
Johnson CD Platelet-activating factor and platelet-activating factor antagonists in acute pancreatitis. 1999 Dig Surg pmid:10207233
Hasselwander O et al. HDL composition and HDL antioxidant capacity in patients on regular haemodialysis. 1999 Atherosclerosis pmid:10208487
Klettke U et al. Platelet-activating factor inhibits ciliary beat frequency of human bronchial epithelial cells. 1999 Mar-Apr Allergy Asthma Proc pmid:10209689
Wang X et al. Treatment with lexipafant ameliorates the severity of pancreatic microvascular endothelial barrier dysfunction in rats with acute hemorrhagic pancreatitis. 1999 Int. J. Pancreatol. pmid:10211421
Nagahata Y et al. Role of platelet activating factor on severity of ischemic colitis. 1999 Dis. Colon Rectum pmid:10211499
Zardini DM and Tschirhart EJ [Selective differentiation and proliferation of human eosinophils from umbilical cord blood: calcium fluxes and superoxide ion secretion]. 1999 Jan-Feb Therapie pmid:10216433
Van de Weerdt ML et al. Role of the cholinergic pathway in mediating platelet-activating factor-induced pulmonary dysfunctions in unsedated calves. 1999 Zentralbl Veterinarmed A pmid:10216447
Hüseyinov A et al. Increased gastric production of platelet-activating factor, leukotriene-B4, and tumor necrosis factor-alpha in children with Helicobacter pylori infection. 1999 Dig. Dis. Sci. pmid:10219821
Lee IS et al. Structure-activity relationships of lignans from Schisandra chinensis as platelet activating factor antagonists. 1999 Biol. Pharm. Bull. pmid:10220282
Harrison KA et al. Negative ion electrospray and tandem mass spectrometric analysis of platelet activating factor (PAF) (1-hexadecyl-2-acetyl-glycerophosphocholine). 1999 J Mass Spectrom pmid:10226361
Bastien Y et al. Detection of functional platelet-activating factor receptors on human tonsillar B lymphocytes. 1999 J. Immunol. pmid:10228030
Amroyan E et al. Inhibitory effect of andrographolide from Andrographis paniculata on PAF-induced platelet aggregation. 1999 Phytomedicine pmid:10228608
Han SJ et al. Glucocorticoids prevent NF-kappaB activation by inhibiting the early release of platelet-activating factor in response to lipopolysaccharide. 1999 Eur. J. Immunol. pmid:10229101
Tool AT et al. Phospholipase D-derived phosphatidic acid is involved in the activation of the CD11b/CD18 integrin in human eosinophils. 1999 Biochem. J. pmid:10229663
Hirashima Y et al. Deficient platelet-activating factor and related enzymes in hemimegalencephaly. 1999 Childs Nerv Syst pmid:10230665
Reinhardt JC et al. Immunofluorescent evidence of the platelet-activating factor receptor on human spermatozoa. 1999 Fertil. Steril. pmid:10231061
López-Novoa JM Potential role of platelet activating factor in acute renal failure. 1999 Kidney Int. pmid:10231429
Yamaguchi Y et al. Platelet-activating factor antagonist (TCV-309) attenuates the priming effects of bronchoalveolar macrophages in cerulein-induced pancreatitis rats. 1999 Pancreas pmid:10231840
Jenks PJ et al. Comparison of weal and flare responses to platelet activating factor (PAF) and histamine, and the ultrastructural effects of PAF in the skin of atopic and normal subjects. 1999 Clin. Exp. Dermatol. pmid:10233666
Kavakli K et al. Plasma platelet-activating factor (PAF) levels and desmopressin response in children with hemophilia A and von Willebrand's disease. 1999 Thromb. Haemost. pmid:10235463
Dong JC et al. [Experimental study on antagonism of ginkgolides against effect of platelet-activating factor on lung strip of guinea pigs]. 1997 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:10322836
Denizot Y et al. Are lipid mediators implicated in the production of pro- and anti-inflammatory cytokines during cardiopulmonary bypass graft with extracorporeal circulation? 1999 Cytokine pmid:10328869
Rigat B et al. The GM2 activator protein, a novel inhibitor of platelet-activating factor. 1999 Biochem. Biophys. Res. Commun. pmid:10329374
Flickinger BD and Olson MS Localization of the platelet-activating factor receptor to rat pancreatic microvascular endothelial cells. 1999 Am. J. Pathol. pmid:10329588
Mori N et al. Ischemia-reperfusion induced microvascular responses in LDL-receptor -/- mice. 1999 Am. J. Physiol. pmid:10330250
Rhee CK et al. Effect of platelet activating factor and its antagonist on the mucociliary clearance of the eustachian tube in guinea pigs. 1999 Ann. Otol. Rhinol. Laryngol. pmid:10335705
Latorre E et al. Platelet-activating factor modulates brain sphingomyelin metabolism. 1999 Eur. J. Biochem. pmid:10336612
Huang YH et al. Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism. 1999 Clin. Exp. Immunol. pmid:10337026
Markert R and Modzelewski B [Inflammatory mediators in the acute pancreatitis]. 1999 Pol. Merkur. Lekarski pmid:10337184
Alvi SA et al. Corticotrophin-releasing hormone and platelet-activating factor induce transcription of the type-2 cyclo-oxygenase gene in human fetal membranes. 1999 Mol. Hum. Reprod. pmid:10338371
Aliberti JC et al. Platelet-activating factor induces nitric oxide synthesis in Trypanosoma cruzi-infected macrophages and mediates resistance to parasite infection in mice. 1999 Infect. Immun. pmid:10338485
Yoshimura T et al. Estrogen replacement therapy decreases platelet-activating factor-acetylhydrolase activity in post-menopausal women. 1999 Maturitas pmid:10340285
McNulty CA et al. Characterization of the integrin and activation steps mediating human eosinophil and neutrophil adhesion to chronically inflamed airway endothelium. 1999 Am. J. Respir. Cell Mol. Biol. pmid:10340944
Nasu K et al. Platelet-activating factor stimulates cytokine production by human endometrial stromal cells. 1999 Mol. Hum. Reprod. pmid:10341002
Cepinskas G et al. PAF-induced elastase-dependent neutrophil transendothelial migration is associated with the mobilization of elastase to the neutrophil surface and localization to the migrating front. 1999 J. Cell. Sci. pmid:10341212
Mariano F et al. Production of platelet-activating factor in patients with sepsis-associated acute renal failure. 1999 Nephrol. Dial. Transplant. pmid:10344354
Rainsford KD Inhibition by leukotriene inhibitors, and calcium and platelet-activating factor antagonists, of acute gastric and intestinal damage in arthritic rats and in cholinomimetic-treated mice. 1999 J. Pharm. Pharmacol. pmid:10344635
Cruzado JM et al. Effect of human natural xenoantibody depletion and complement inactivation on early pig kidney function. 1999 May-Jun Exp. Nephrol. pmid:10352362
Svetlov SI et al. Decreased intraplatelet Ca2+ release and ATP secretion in pediatric nephrotic syndrome. 1999 Pediatr. Nephrol. pmid:10353406
Weber C et al. Effects of oxidized low density lipoprotein, lipid mediators and statins on vascular cell interactions. 1999 Clin. Chem. Lab. Med. pmid:10353467
Del Sorbo L et al. The synthesis of platelet-activating factor modulates chemotaxis of monocytes induced by HIV-1 Tat. 1999 Eur. J. Immunol. pmid:10359105
Crawford SE et al. Captopril and platelet-activating factor (PAF) antagonist prevent cardiac allograft vasculopathy in rats: role of endogenous PAF and PAF-like compounds. 1999 J. Heart Lung Transplant. pmid:10363692
Goldman R et al. Calcium-dependent PAF-stimulated generation of reactive oxygen species in a human keratinocyte cell line. 1999 Biochim. Biophys. Acta pmid:10366777
Steil AA et al. Platelet-activating factor and eicosanoids are mediators of local and systemic changes induced by immune-complexes in mice. 1999 Prostaglandins Other Lipid Mediat. pmid:10367295
Martínez L et al. Nitroprusside stimulates contractility and the synthesis of 14C-acetylated PAF-like substances in estrogen primed-mouse uterine horns. 1999 Prostaglandins Other Lipid Mediat. pmid:10367296
Cahana A and Reiner O LIS1 and platelet-activating factor acetylhydrolase (Ib) catalytic subunits, expression in the mouse oocyte and zygote. 1999 FEBS Lett. pmid:10371146
Diaz E et al. Presence of platelet-activating factor in rhesus (Macaca mulatta) spermatozoa. 1999 J. Med. Primatol. pmid:10372538
Rosenbaum JT et al. Intravitreally injected platelet activating factor induces retinitis in experimental animals. 1999 Curr. Eye Res. pmid:10372995
Xiao J et al. Synergetic protective effects of combined blockade by two kinds of autolesion mediator receptor on neurological function after cervical cord injury. 1998 Chin. Med. J. pmid:10374355
Ji Z et al. [The role of platelet activating factor in pathogenesis of acute pancreatitis in dogs]. 1997 Zhonghua Wai Ke Za Zhi pmid:10374489
Yi FX and Guo ZG Platelet-released ADP stabilizes PAF-induced rabbit platelet aggregation by stabilizing intracellular calcium. 1998 Zhongguo Yao Li Xue Bao pmid:10375790
Wang Y et al. Increased neutrophil-endothelial adhesion induced by placental factors is mediated by platelet-activating factor in preeclampsia. 1999 May-Jun J. Soc. Gynecol. Investig. pmid:10376269
Callea L et al. Platelet activating factor is elevated in cerebral spinal fluid and plasma of patients with relapsing-remitting multiple sclerosis. 1999 J. Neuroimmunol. pmid:10376955
McNeil RS et al. Neuronal cytoskeletal alterations evoked by a platelet-activating factor (PAF) analogue. 1999 Cell Motil. Cytoskeleton pmid:10379835
Deigner HP et al. Novel reversible, irreversible and fluorescent inhibitors of platelet-activating factor acetylhydrolase as mechanistic probes. 1999 Atherosclerosis pmid:10381281
Bandeira-Melo C et al. Suppressive effect of distinct bradykinin B2 receptor antagonist on allergen-evoked exudation and leukocyte infiltration in sensitized rats. 1999 Br. J. Pharmacol. pmid:10385228
Guilbert M et al. 5-Oxo-6,8,11,14-eicosatetraenoic acid induces important eosinophil transmigration through basement membrane components: comparison of normal and asthmatic eosinophils. 1999 Am. J. Respir. Cell Mol. Biol. pmid:10385597
Fujii E et al. Microvascular permeability change induced by platelet-activating factor is impaired in diabetic mice. 1999 Microvasc. Res. pmid:10388605
Forte TM et al. Targeted disruption of the murine lecithin:cholesterol acyltransferase gene is associated with reductions in plasma paraoxonase and platelet-activating factor acetylhydrolase activities but not in apolipoprotein J concentration. 1999 J. Lipid Res. pmid:10393212
Subramanian VS et al. Role of lecithin-cholesterol acyltransferase in the metabolism of oxidized phospholipids in plasma: studies with platelet-activating factor-acetyl hydrolase-deficient plasma. 1999 Biochim. Biophys. Acta pmid:10395969
Kulikov VI and Muzya GI Mechanisms of interaction of a plasmalogenic analog of platelet-activating factor with human platelets. 1999 Biochemistry Mosc. pmid:10395976
Strukova SM et al. Modulation of mast cell activity by a peptide agonist of the thrombin receptor: role of nitric oxide. 1999 Biochemistry Mosc. pmid:10395981
Ishii S and Shimizu T [Platelet-activating factor (PAF) receptor-related pathophysiology]. 1999 Tanpakushitsu Kakusan Koso pmid:10396985